CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED

Autres langues China Resources Pharmaceutical Group Limited

Actions

3320

HK0000311099

Produits pharmaceutiques

Marché Fermé - Hong Kong S.E. Autres places de cotation 10:08:21 29/07/2026			Varia. 5j.	Varia. 1 janv.
4,900 ^HKD	+1,24%		+2,51%	+10,11%

22/07	Une filiale de China Resources Pharma lève 1 milliard de yuans par émission obligataire	MT
16/07	Une filiale de China Resources Pharma en tête pour le rachat d'une participation dans Lier Chemical	MT

Autres langues

22/07	China Resources Pharma Unit Sells 1 Billion Yuan Bonds
16/07	China Resources Pharma Unit Emerges Top Bidder for Lier Chemical Stake
14/07	CR Sanjiu's Profit Slips 7.9% in H1
13/07	China Resources Pharmaceutical Group Limited Announces Board Changes, Effective July 13, 2026
29/06	China Resources Pharmaceutical Unit Sells 2 Billion Yuan Bonds
01/06	China Resources Pharma Unit Gets China Acceptance for 5 Billion Yuan Bond Issue; Shares Climb 3%
28/04	China Resources Pharmaceutical Unit Sells 1.4 Billion Yuan Bonds
27/04	Jiang Zhong Pharmaceutical's Profit Rises in Q1
27/04	Dong-E-E-Jiao's Profit Jumps 7% in Q1, Revenue Up 5.5%
27/04	CR Double-Crane's Profit, Revenue Fall in Q1
24/04	China Resources Pharmaceutical says CR Boya Bio-Pharmaceutical posts quarterly unaudited revenue RMB 321.1 million, net profit RMB 30.0 million
24/04	China Resources Pharmaceutical says Q1 net profit for CR Double-Crane is RMB501.4 mln
24/04	China Resources Pharmaceutical says Q1 net profit for CR Jiangzhong RMB312.0 mln
16/04	China Resources Pharma Unit Sells 1.5 Billion Yuan Bonds
25/03	China Resources Pharmaceutical's Profit Climbs in 2025; EPS, Revenue Top Estimates
25/03	China Resources Pharmaceutical posts FY profit attributable of RMB4.05 billion
24/03	China Resources Pharmaceutical Group Limited Recommends Final Dividend for the Year Ended 31 December 2025, Payable on About 03 August 2026
24/03	China Resources Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2025
20/03	China Resources Pharmaceutical logs FY revenue RMB2.06 bln for CR Boya Bio-pharmaceutical
20/03	Tasly Pharmaceutical's Profit Rises 16% in 2025
20/03	Jiang Zhong Pharmaceutical's Profit Jumps 15% in 2025
19/03	China Resources Pharmaceutical proposes cash dividend RMB14.31 per 10 shares of Dong-E-E-Jiao
19/03	China Resources Pharmaceutical says KPC Pharmaceuticals proposes dividend of RMB1.80 per 10 shares
16/03	China Resources Pharmaceutical discloses potential disposal of Tianmai Biotechnology
10/02	China Resources Pharma Unit Mulls Sale of Nearly 18% Stake in Tianmai Biotechnology